3^rd International Conference on Systems and Synthetic Biology July 20-21, 2017 Munich, Germany

Martin Falk has completed his Ph.D from Masaryk University in Brno, CR. He is the leader of the Department of Cell Biology and Radiobiology at the Institute of Biophysics of the Czech Academy of Sciences (Brno, CR). He participated in more than 30 papers that concern the role of chromatin structure in regulation of cellular processes. The research interests include DNA damage and repair, carcinogenesis, tumor cells radio-sensitization, and radiobiology.

Dr.Martin Falk has research interests in DNA damage and repair, carcinogenesis, tumor cells radio-sensitization, and radiobiology.

Dr. Mu has completed his PhD from Gunma University/Japan and postdoctoral studies at Kyoto University, Carnegie Mellon University and University of Pittsburgh. He is the board certified toxicologist and a researcher at the FDA. He has published more than 25 papers in reputed journals and is interested in the development of biomarkers for allergic risk assessment.

Dr.Ying MU has long time experience in the development of biomarkers for allergic risk assessment.

Professor Krams holds a Chair in Molecular Bioengineering at Imperial College, London. Prior to joining Imperial College he worked as Associate Professor in the department Bioengineering, Thoraxcentre Rotterdam, the Netherlands and as associate professor/chair in the department of Medical Physics, Free University in Amsterdam. He received his Medical Degree and Ph.D. from the Free University, Amsterdam in 1989.

Dr.Rob Krams research is focussed on the molecular mechanism underlying biomechanical stimuli. To that end he uses a combination of engineering techniques (imaging, systems biology and synthetic biology) and molecular techniques (high throughput, qPCR, life cell imaging) to study the interaction of gene expression and shear stress and wall stress on cells in culture and in whole animals.

Albert Jeltsch finished his PhD on restriction endonucleases at University Hannover in 1994. Afterwards he started working on DNA methyltransferases at Justus-Liebig University Giessen and and Jacobs University Bremen. Since 2011, he is professor of Biochemistry at the University Stuttgart. He received the Gerhard-Hess award (DFG) and BioFuture award (BMBF). Prof. Jeltsch has long standing expertise in the biochemical study of DNA and protein methyltransferases, methyl lysine reading domains and in rational and evolutionary protein design. His work has been published in >200 publications in peer reviewed journals and he is in the editorial boards of several journals.

Prof. Jeltsch has long standing expertise in the biochemical study of DNA and protein methyltransferases, methyl lysine reading domains and in rational and evolutionary protein design.

Dr. Ingy Moustafa Hashad’s work involved the study of “contribution of the p22 phox gene of NAD(P)H oxidase and eNOS gene polymorphisms in the predisposition of early onset acute myocardial infarction in Egyptian population”. She learnt several techniques through her research including, conventional PCR and SNP analysis, ELISA, electrophoresis, and spectrophotometric determinations. She finished successfully her Ph.D. in May 2012 with great appraisal from the supervisors and examiners. Later, she had the opportunity to spend three months summer research in the research lab of Prof. Wolfgang Poller, Charité Centrum für Herz-, Kreislauf- und Gefäßmedizin and another three months in the research lab of Prof. Michael Bader, Max-Delbruck Center for Molecular Medicine, Berlin, Germany which added to her scientific and technical knowledge and skills.

The research interests include Biochemical Markers Genetics and Cardiovascular Diseases

Arvydas tamulis has completed his Ph.D. degree of the Theoretical and Mathematical Physics in Vilnius University in 1985.He worked has a Research Fellow at the Institute of Physics of the Lithuanian Academy of Sciences from 1985-1996.At Present he is working as a Senior researcher at the Institute of Theoretical Physics and Astronomy, Vilnius University. Total number of scientific publications 228: 5 chapters of books, 117 scientific articles in the refered issues (67 of them in the ISI Web of Science list with the impact factor). Science presentations in more than 100 conferences and symposia in Lithuania, Russia, Poland, England, Wales, Scotland, Germany, Japan, Denmark, Norway, Sweden, Italy, Spain, France, Netherlands and USA. During 22 years of restored Lithuanian independancy have sucessfuly participated in 27 scientific projects.

Dr.Arvydas tamulis is interested in Quantum self-assembly of prebiotic kernels and minimal protocells; Quantum entangled photosynthesis in prebiotic kernels and minimal protocells; Electron density and electron spin density transfer in minimal biosystems; Quantum entangled logical gates and quantum entangled information processing in minimal biosystems; Importance of quantum entanglement in the first stages of origins of life and evolution of the biospheres; Correlations of fine tuned quantum mechanical laws with determined consequences of the emergence of life and further evolution.

Dr. Ingy Moustafa Hashad’s work involved the study of “contribution of the p22 phox gene of NAD(P)H oxidase and eNOS gene polymorphisms in the predisposition of early onset acute myocardial infarction in Egyptian population”. She learnt several techniques through her research including, conventional PCR and SNP analysis, ELISA, electrophoresis, and spectrophotometric determinations. She finished successfully her Ph.D. in May 2012 with great appraisal from the supervisors and examiners. Later, she had the opportunity to spend three months summer research in the research lab of Prof. Wolfgang Poller, Charité Centrum für Herz-, Kreislauf- und Gefäßmedizin and another three months in the research lab of Prof. Michael Bader, Max-Delbruck Center for Molecular Medicine, Berlin, Germany which added to her scientific and technical knowledge and skills.

Dr.Ingy Hashad is interested in Biochemical Markers, Genetics and Cardiovascular Diseases.

Davide De Lucrezia is currently the CEO of Explora Biotech Srl, a biotech dynamic company he co-founded in 2006 and adjunct professor in Bio-nanomaterial at University Ca Foscari Venezia. Until 2012 he served as operative coordinator of the LivingTech Lab at the European Centre for Living Technology (Venice, Italy). He graduated in 2004 in Biology at the University of Rome “Roma Tre” and pursued a PhD degree in biochemistry in 2009. Prior joining ECLT he has been head of the pharmacokinetics and metabolomics unit at San Raffaele Hospital in Rome. In 2001-2003 he was staff scientist at Polyphor AG (Switzerland), and research technician at the Swiss Federal Institute of Technology of Zurich. He wrote several papers published in international peer-reviewed journals and books for both specialized and general audience and is the inventor of 1 patent. He has been involved in several European and international projects both as coordinator (THEGRAIL and NEXT projects) and WP leader (MAGISTER, ETOILE, AMCARE, DRIVE, LIAR and TOPCAPI). He also leverages his competences in IP strategic management for private investor and biotech companies at both national, European (EPO) and International (PCT)

Davide De Lucrezia main research of interest mainly focuses on System and Synthetic Biology and In vitro evolution of protein and nucleic acid, chemical synthetic biology of protein and nucleic acid.

Dr. Arkun has held visiting positions at Tennessee Eastman, DuPont and Weyerhauser companies. He has served as the North American editor of Journal of Process Control and Associate Editor of Automatica. He has been a trustee and secretary of Computer Aids in Chemical Engineering (CACHE) Corporation, and a director of Computers and Systems Technology (CAST) Division of AIChE. He is the 1986 recipient of the Donald P. Eckman Award given by the American Automatic Control Council He received TÃœBÄ°TAK (The Sientific and Technological Research Council of Turkey) Science Award in 2004. He was elected to TÃœBA (Turkish Academy of Sciences) in 2006 and he is a member of the Scientific Board of TÃœBÄ°TAK.

Dr. Arkun's research interests are in process dynamics, modeling and control of chemical and biological systems. Research topics include dynamic modeling, model predictive control, large scale complex and hierarchical systems, optimization. Current application areas are copolymerization reactors, refinery operations, protein folding and systems biology.